Moreover, while no function of HSC VCAM-1 in liver fibrosis was found here, we cannot exclude that VCAM-1 in other cells could be a therapeutic target in NASH. The gene discussed is VCAM1; the disease is metabolic dysfunction-associated steatohepatitis.